SecSonar.com

IQVIA Holdings Inc. (IQV)

IQVIA Holdings Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

IQVIA Holdings Inc. (IQV) is a Medical - Diagnostics & Research company based in US with a market capitalization of $30.5B. Revenue grew 5.9% year-over-year and the company generated $2.1B in free cash flow. This page tracks IQV's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 89K employees · IPO May 9, 2013

Valuation

Valuation & price

$169.12 · as of May 17, 2026 · -30.8% vs 52w high

21.6

P/E ratio

Latest-FY diluted EPS

4.70

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$243$200$158Jul 25Dec 25Jul 26Jul 7, 25$162.45Jul 9, 25$162.02Jul 11, 25$162.80Jul 15, 25$157.68Jul 17, 25$163.25Jul 21, 25$158.96Jul 23, 25$194.24Jul 25, 25$199.17Jul 29, 25$194.55Jul 31, 25$185.86Aug 4, 25$182.75Aug 6, 25$177.49Aug 11, 25$180.09Aug 13, 25$190.23Aug 15, 25$191.09Aug 19, 25$192.35Aug 21, 25$185.39Aug 25, 25$188.02Aug 27, 25$188.80Aug 29, 25$190.81Sep 3, 25$184.62Sep 5, 25$187.68Sep 9, 25$189.64Sep 11, 25$190.69Sep 16, 25$186.81Sep 18, 25$190.20Sep 22, 25$187.83Sep 24, 25$181.24Sep 26, 25$179.56Sep 30, 25$189.94Oct 2, 25$204.34Oct 6, 25$205.02Oct 8, 25$200.60Oct 10, 25$198.17Oct 14, 25$204.76Oct 16, 25$205.75Oct 21, 25$218.67Oct 23, 25$219.91Oct 27, 25$217.43Oct 29, 25$217.83Oct 31, 25$216.46Nov 4, 25$210.96Nov 6, 25$210.86Nov 10, 25$213.05Nov 12, 25$220.88Nov 14, 25$220.61Nov 18, 25$217.28Nov 20, 25$217.11Nov 25, 25$231.92Nov 28, 25$230.01Dec 2, 25$225.63Dec 4, 25$224.92Dec 8, 25$223.57Dec 10, 25$222.92Dec 12, 25$222.26Dec 16, 25$221.68Dec 18, 25$222.52Dec 22, 25$224.37Dec 24, 25$226.02Dec 29, 25$227.11Jan 2, 26$225.37Jan 6, 26$240.53Jan 8, 26$243.19Jan 12, 26$240.86Jan 14, 26$241.35Jan 16, 26$237.68Jan 21, 26$241.40Jan 23, 26$235.31Jan 27, 26$241.04Jan 29, 26$235.62Feb 2, 26$231.23Feb 4, 26$202.54Feb 9, 26$192.67Feb 11, 26$177.18Feb 13, 26$166.94Feb 18, 26$171.06Feb 20, 26$165.62Feb 24, 26$164.88Feb 26, 26$170.64Mar 2, 26$174.27Mar 4, 26$177.88Mar 6, 26$174.49Mar 10, 26$170.93Mar 12, 26$162.93Mar 17, 26$168.43Mar 19, 26$166.47Mar 23, 26$166.96Mar 25, 26$165.64Mar 27, 26$163.85Mar 31, 26$170.54Apr 2, 26$173.26Apr 7, 26$170.62Apr 9, 26$168.98Apr 13, 26$171.99Apr 15, 26$178.10Apr 17, 26$176.46Apr 22, 26$175.21Apr 24, 26$162.28Apr 28, 26$158.98Apr 30, 26$158.37May 4, 26$160.94May 6, 26$176.47May 8, 26$178.71May 12, 26$175.06May 14, 26$170.68May 18, 26$172.81May 20, 26$171.50May 22, 26$167.90May 28, 26$181.09Jun 1, 26$186.82Jun 3, 26$182.05Jun 5, 26$183.45Jun 9, 26$186.25Jun 11, 26$181.06Jun 15, 26$178.39Jun 17, 26$170.67Jun 22, 26$167.81Jun 24, 26$185.62Jun 26, 26$191.14Jul 2, 26$207.04
$156.6652-week range$244.29
Loading valuation history…

Fundamentals

Key fundamentals

$30.5B

Market cap

5.9%

Revenue growth (YoY)

26.3%

Gross margin

$2.1B

Free cash flow (USD)

$14B

Net debt

-5.2%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$6.8BFY 2017$9.7BFY 2018$10.4BFY 2019$11.1BFY 2020$11.4BFY 2021$13.9BFY 2022$14.4BFY 2023$15.0BFY 2024$15.4BFY 2025$16.3B
$6.8B$16.3B

Free cash flow by year

2016 → 2025

FY 2016$696.0MFY 2017$601.0MFY 2018$795.0MFY 2019$835.0MFY 2020$1.3BFY 2021$2.3BFY 2022$1.6BFY 2023$1.5BFY 2024$2.1BFY 2025$2.1B
$696M$2.1B

Gross margin by year

2021 → 2025

FY 202133.5%FY 202234.9%FY 202335.0%FY 202434.9%FY 202526.3%
33.5%26.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 5, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventDebt IssuanceJun 11, 2026Filing
  • 8-K eventDebt Offering PricedJun 4, 2026Filing
  • 8-K eventDebt RefinancingJun 3, 2026Filing
  • 8-K eventShare RepurchaseMay 7, 2026Filing
  • 8-K eventEarnings ReleaseMay 5, 2026Filing
  • Quarterly report10-Q FiledMay 5, 2026Filing
  • 8-K eventIncentive Plan EstablishedApr 23, 2026Filing

Questions

Frequently asked questions

What is IQVIA Holdings Inc.'s market cap?

IQVIA Holdings Inc. (IQV) has a market capitalization of $30.5B.

What is IQV's P/E ratio?

IQV trades at a price-to-earnings ratio of 21.6, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is IQV's price-to-book (P/B) ratio?

IQV trades at 4.70 times book value per share.

Are insiders buying IQV stock?

SEC Form 4 filings show no open-market insider buys at IQVIA Holdings Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Diagnostics & Research

NTRA

Natera, Inc.

$31.7B

WAT

Waters Corporation

$25B

ILMN

Illumina, Inc.

$25B

MTD

Mettler-Toledo International Inc.

$23.8B

A

Agilent Technologies, Inc.

$38.7B

DGX

Quest Diagnostics Incorporated

$21.6B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.